SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MGV who wrote (1673)2/24/2000 1:12:00 PM
From: Sam Citron  Read Replies (2) of 1754
 
I'd expect B&L to wait for the PTO decision expected in March before deciding whether to license.

"With regard to procedural fees, Bausch & Lomb has evaluated the complex issues presented by various patents in the U.S. and believes that it can market the Technolas 217 without obtaining further rights under third-party patents. The company will collect a fee of $100 for each procedure performed with its laser."

biz.yahoo.com

Does this resolve the licensing issue?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News